Evidence map›Paper›PMID 28443195›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2014

Synthesis, quality control and determination of metallic impurities in

Krzysztof Kilian, Bartłomiej Chabecki, Justyna Kiec, Agnieszka Kunka, Barbara Panas, Maciej Wójcik, Anna Pękal

Abstract read
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Easy and versatile preparation ofEJNMMI radiopharmacy and chemistry · 2026
    Article
  2. The next generation of medical physicists.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Krzysztof KilianUniversity of Warsaw, Heavy Ion Laboratory, Pasteur 5a, 02-093 Warsaw, Poland.
Bartłomiej ChabeckiUniversity of Warsaw, Department of Physics, Hoża 69, 00-681 Warsaw, Poland.
Justyna KiecUniversity of Warsaw, Department of Physics, Hoża 69, 00-681 Warsaw, Poland.
Agnieszka KunkaUniversity of Warsaw, Department of Physics, Hoża 69, 00-681 Warsaw, Poland.
Barbara PanasUniversity of Warsaw, Department of Physics, Hoża 69, 00-681 Warsaw, Poland.
Maciej WójcikUniversity of Warsaw, Department of Physics, Hoża 69, 00-681 Warsaw, Poland.
Anna PękalUniversity of Warsaw, Heavy Ion Laboratory, Pasteur 5a, 02-093 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe aim of this study was to synthesize

backgroundFor radiopharmaceuticals the general requirements are listed in European Pharmacopeia and these parameters have to be checked before application for human use. MATERIALS AND

methodsStandard methods for the determination of basic characteristics of radiopharmaceuticals were used. Additionally, high resolution γ spectrometry was used for the assessment of nuclidic purity and inductively coupled plasma with mass spectrometry to evaluate metallic content.

resultsResults showed sources and distribution of metallic and radiometallic impurities in the production process. Main part is trapped in the initial separation column of the synthesis unit and is not distributed to the final product in significant amounts.

conclusionsProduced

Indexed as

18FDGGamma-spectrometryRadionuclidic impuritiesRadiopharmaceuticals

Identifiers

PMID28443195
PMCPMC5394716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.